- GTHX +1.13%
G1 Therapeutics, Inc. (NASDAQ:GTHX) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Yahoo Finance · 1 day ago
Open | 4.5600 |
High | 4.7000 |
Low | 4.4800 |
Mkt Cap | 234.85M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 4.4400 |
52 Wk. Low | 1.0800 |
52 Wk. High | 5.0000 |
Related stocks
Pharmaceutical company
G1 Therapeutics, Inc. is an American biopharmaceutical company headquartered in Research Triangle Park, North Carolina. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 14.48M | 11.80% ▲ |
Net Income | -10.22M | - |
Diluted EPS | -0.20 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.17 | - |
Q1 2024 | -$0.21 | -$0.20 |
Q4 2023 | -$0.27 | -$0.21 |
S&P 500^GSPC | 5,127.79+63.59 (+1.26%) |
Dow 30^DJI | 38,675.68+449.98 (+1.18%) |
Nasdaq^IXIC | 16,156.33+315.33 (+1.99%) |
113.66+0.92% | |
55.26+0.64% | |
146.43-0.54% |